Related Experiment Videos
Peroxisome proliferator-activated receptors.
Ouliana Ziouzenkova1, Stephane Perrey, Niko Marx
1Division of Cardiovascular Medicine, Brigham and Women's Hospital, 221 Longwood Avenue, LMRC 307, Boston, MA 02115, USA.
Current Atherosclerosis Reports
|January 5, 2002
Summary
Peroxisome proliferator-activated receptors (PPARs) are increasingly recognized for their roles in vascular biology and atherosclerosis. PPAR activators are clinically used for diabetes and dyslipidemia, highlighting their therapeutic potential.
Area of Science:
- Vascular Biology
- Atherosclerosis Research
- Nuclear Receptor Function
Background:
- Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors with established roles in metabolism.
- Recent research highlights PPAR expression in vascular and inflammatory cells.
- Understanding PPARs' function in vascular health and disease is an evolving area.
Purpose of the Study:
- To review the emerging roles of PPARs in vascular biology and atherosclerosis.
- To connect the established clinical applications of PPAR activators with their vascular functions.
- To emphasize the significance of PPARs in the context of cardiovascular disease risk.
Main Methods:
- Literature review of recent advancements in PPAR research.
- Analysis of studies investigating PPAR expression in vascular and inflammatory cells.
- Correlation of clinical data with experimental findings on PPAR function.
Main Results:
- PPARs are expressed in key vascular and inflammatory cells.
- PPARs play significant roles in regulating vascular biology and the atherosclerotic process.
- Clinical use of PPAR activators (thiazolidinediones and fibrates) is widespread for metabolic disorders.
Conclusions:
- PPARs represent a critical link between metabolic regulation and vascular health.
- PPAR activators have demonstrated therapeutic benefits in managing cardiovascular risk factors.
- Further research into PPAR mechanisms may unveil new therapeutic strategies for atherosclerosis.